<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Kietaibl AT</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Euglycemic diabetic ketoacidosis (EDKA) is a potentially life-threatening condition and a reported side effect of antidiabetic sodium-glucose-cotransporter-2-inhibitors (SGLT2-I). The analysis of the herein presented case and its management formed the incentive to prepare this multidisciplinary work and includes an overview about perioperative SGLT2-I-induced ketoacidosis.&lt;h4>Method&lt;/h4>A PubMed search on relevant entries was conducted combining the terms "euglycemic diabetic ketoacidosis" AND "surgery."&lt;h4>Results&lt;/h4>A total of 33 articles on SGLT2-I-induced ketoacidosis in the context of surgical treatment were identified. According to this literature research risk factors for the development are infection, perioperative fasting, surgical stress, and insulin dose redu</pubmed_abstract><journal>Frontiers in surgery</journal><pagination>828649</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8987984</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>New Diabetic Medication Sodium-Glucose Cotransporter-2 Inhibitors Can Induce Euglycemic Ketoacidosis and Mimic Surgical Diseases: A Case Report and Review of Literature.</pubmed_title><pmcid>PMC8987984</pmcid><pubmed_authors>Glaser K</pubmed_authors><pubmed_authors>Kietaibl AT</pubmed_authors><pubmed_authors>Fasching P</pubmed_authors><pubmed_authors>Petter-Puchner AH</pubmed_authors></additional><is_claimable>false</is_claimable><name>New Diabetic Medication Sodium-Glucose Cotransporter-2 Inhibitors Can Induce Euglycemic Ketoacidosis and Mimic Surgical Diseases: A Case Report and Review of Literature.</name><description>&lt;h4>Background&lt;/h4>Euglycemic diabetic ketoacidosis (EDKA) is a potentially life-threatening condition and a reported side effect of antidiabetic sodium-glucose-cotransporter-2-inhibitors (SGLT2-I). The analysis of the herein presented case and its management formed the incentive to prepare this multidisciplinary work and includes an overview about perioperative SGLT2-I-induced ketoacidosis.&lt;h4>Method&lt;/h4>A PubMed search on relevant entries was conducted combining the terms "euglycemic diabetic ketoacidosis" AND "surgery."&lt;h4>Results&lt;/h4>A total of 33 articles on SGLT2-I-induced ketoacidosis in the context of surgical treatment were identified. According to this literature research risk factors for the development are infection, perioperative fasting, surgical stress, and insulin dose redu</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-19T21:49:59.393Z</modification><creation>2025-04-19T21:49:59.393Z</creation></dates><accession>S-EPMC8987984</accession><cross_references><pubmed>35402477</pubmed><doi>10.3389/fsurg.2022.828649</doi></cross_references></HashMap>